Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia

A 16-year-old patient with acute lymphoblastic leukaemia which had relapsed for the third time developed clinical signs and symptoms of septicemia during a period of neutropenia. The patient had signs of oral mucositis, and Stomatococcus mucilaginosus was isolated from blood cultures. The patient re...

Full description

Saved in:
Bibliographic Details
Published in:European journal of clinical microbiology & infectious diseases 1998-07, Vol.17 (7), p.505-507
Main Authors: TREVINO, M, GARCIA-ZABARTE, A, QUINTAS, A, VARELA, E, LOPEZ-PAZ, J. M, JATO, A, GARCIA-RIESTRA, C, REGUEIRO, B. J
Format: Article
Language:English
Subjects:
Adolescent
Anti-Bacterial Agents - pharmacology
Bacterial diseases
Bacterial sepsis
Biochemistry
Biological and medical sciences
Gram-Positive Bacterial Infections - complications
Gram-Positive Bacterial Infections - microbiology
Human bacterial diseases
Humans
Immunosuppression
Infectious diseases
Leukemia
Male
Medical research
Medical sciences
Microbial Sensitivity Tests
Micrococcaceae - classification
Micrococcaceae - drug effects
Micrococcaceae - isolation & purification
Pharynx - microbiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma - microbiology
Sepsis - complications
Sepsis - microbiology
Stomatococcus mucilaginosus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 16-year-old patient with acute lymphoblastic leukaemia which had relapsed for the third time developed clinical signs and symptoms of septicemia during a period of neutropenia. The patient had signs of oral mucositis, and Stomatococcus mucilaginosus was isolated from blood cultures. The patient responded well to antibiotic therapy. The biochemical characteristics and antimicrobial susceptibility patterns of 68 other pharyngeal isolates of Stomatococcus mucilaginosus from immunocompromised patients are presented.
ISSN:0934-9723
1435-4373
DOI:10.1007/BF01691134